サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1750843

神経ラップの市場規模、シェア、動向分析レポート：手術別、用途別、地域別、セグメント予測、2025年～2030年

Nerve Wrap Market Size, Share & Trends Analysis Report By Surgery (Direct Nerve Repair, Nerve Grafting), By Application (Lower Extremities, Upper Extremities), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
神経ラップの市場規模、シェア、動向分析レポート：手術別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月14日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経ラップの市場規模と動向：

神経ラップの世界市場規模は2024年に1億9,831万米ドルと推計され、2025年から2030年にかけてCAGR 9.13％で成長すると予測されています。

この市場成長の主な要因は、末梢神経損傷（PNI）の有病率の増加と、神経修復のための高度な外科的ソリューションの採用が増加していることです。

神経ラップは、瘢痕組織の形成を防ぎ、術後の最適な神経再生を促進するために使用されることが多くなっています。バロー神経学研究所によると、PNIの多くは上肢、特に手首と手に発生し、神経ラップは患者の転帰を改善する臨床的効果を実証しています。ヘルスケア・プロバイダーが低侵襲で効果的な神経修復戦略を優先する中、神経ラップの需要は予測期間を通じて着実に増加すると予想されます。

外傷、外科手術、手根管症候群などの神経圧迫症候群の増加により、神経ラップのような神経保護・再生ソリューションの需要が大幅に増加しています。米国立衛生研究所（NIH）が発表した報告書によると、2022年10月、世界人口の約2.4％が末梢神経障害に罹患しており、高齢者では有病率が8％に上昇します。さらに、2023年8月のNIHの報告によると、神経圧迫症候群は一般集団でよく報告される病態であり、重症度は軽度の不快感から重度の障害に及ぶ。

糖尿病などの慢性疾患は神経損傷の主な原因であり、しばしば神経障害を引き起こします。糖尿病、特に2型糖尿病の世界の有病率の増加は、神経修復・保護ソリューションに対する需要の増加と直接的な相関関係があります。クリーブランド・クリニックによると、2型糖尿病は最も一般的な糖尿病であり、糖尿病患者の90％から95％を占め、神経ラップ市場の成長を牽引しています。

感染リスクの低減、回復の早さ、術後疼痛の軽減といった利点から、末梢神経修復術では低侵襲手術法がますます好まれるようになっています。神経ラップは、修復された神経を覆い、緊張を緩和し、瘢痕組織の形成を抑制することでこれらのプロセスを強化し、その結果、機能回復が促進され、長期的な結果が得られます。このような進歩により、より安全で効果的な手術が可能になり、臨床現場での神経ラップの応用が広がっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の神経ラップ市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 世界神経ラップ市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 価格分析
    • パイプライン分析

第4章 世界の神経ラップ市場：手術の推定・動向分析

  • 世界の神経ラップ市場：ダッシュボード
  • 世界の神経ラップ市場：変動分析
  • 世界の神経ラップ市場：収益別
  • 直接神経修復
  • 神経移植

第5章 世界の神経ラップ市場：用途の推定・動向分析

  • 世界の神経ラップ市場：ダッシュボード
  • 世界の神経ラップ市場：変動分析
  • 世界の神経ラップ市場：収益別
  • 下肢
  • 上肢

第6章 世界の神経ラップ市場：手術、用途、最終用途別の地域推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測動向分析、2018年～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析（2024年）
    • Axogen Corporation
    • Stryker
    • Polyganics BV
    • Integra LifeSciences Corporation.
    • Newrotex
    • AdvaCare Pharma
    • Orthocell Ltd
    • BioCircuit Technologies
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 3 North America Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 5 U.S. Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 6 Canada Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 7 Canada Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 8 Mexico Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 9 Mexico Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 11 Europe Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 12 Germany Nerve Wrap Market, by Surgery, 2018 - 2030 (USD Million)
  • Table 13 Germany Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 15 UK Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 16 France Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 17 France Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 19 Italy Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 21 Spain Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Asia Pacific Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 23 Asia Pacific Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 24 China Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 25 China Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 26 Japan Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 27 Japan Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 28 India Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 29 India Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 30 South Korea Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 31 South Korea Nerve Wrap Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Latin America Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 33 Latin America Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 34 Brazil Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 35 Brazil Nerve Wrap Market, application, 2018 - 2030 (USD Million)
  • Table 36 MEA Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 37 MEA Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 38 South Africa Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 39 South Africa Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 40 Saudi Arabia Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 41 Saudi Arabia Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 42 UAE Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 43 UAE Nerve Wrap Market, by application, 2018 - 2030 (USD Million)
  • Table 44 UAE Nerve Wrap Market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Kuwait Nerve Wrap Market, by surgery, 2018 - 2030 (USD Million)
  • Table 46 Kuwait Nerve Wrap Market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Nerve Wrap market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Surgery and Application segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market dynamics
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 Nerve Wrap market: Surgery outlook and key takeaways
  • Fig. 15 Nerve Wrap market: Surgery movement analysis
  • Fig. 16 Direct Nerve Repair market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Nerve Grafting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Nerve Wrap market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Nerve Wrap market: Application outlook and key takeaways
  • Fig. 20 Nerve Wrap market: Application movement analysis
  • Fig. 21 Lower Extremities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Upper Extremities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Nerve Wrap market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America Nerve Wrap market estimates and forecasts, 2018 - 2030, ((USD million))
  • Fig. 27 Key country dynamics
  • Fig. 28 U.S. Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Key country dynamics
  • Fig. 30 Canada Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Europe Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 UK Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Germany Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 France Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Spain Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Italy Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Denmark Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Sweden Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Norway Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Rest of Europe Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Japan Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 China Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 India Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Australia Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Thailand Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 South Korea Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Rest of Asia Pacific Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Brazil Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Argentina Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Rest of Latin America Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 MEA Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Africa Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Saudi Arabia Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 UAE Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Kuwait Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Rest of MEA Nerve Wrap market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-577-3

Nerve Wrap Market Size & Trends:

The global nerve wrap market size was estimated at USD 198.31 million in 2024 and is projected to grow at a CAGR of 9.13% from 2025 to 2030. This market growth is largely attributed to the increasing prevalence of peripheral nerve injuries (PNIs) and the rising adoption of advanced surgical solutions for nerve repair.

Nerve wraps are increasingly used to prevent scar tissue formation and to promote optimal nerve regeneration post-surgery. According to Barrow Neurological Institute, most PNIs occur in the upper extremities, particularly the wrists and hands, where nerve wraps have demonstrated clinical efficacy in improving patient outcomes. As healthcare providers prioritize minimally invasive and effective nerve repair strategies, the demand for nerve wraps is expected to rise steadily throughout the forecast period.

The growing number of traumatic injuries, surgical procedures, and nerve compression syndromes, such as carpal tunnel syndrome, has significantly increased the demand for nerve protection and regeneration solutions such as nerve wraps. According to a report published by the National Institutes of Health (NIH), in October 2022, approximately 2.4% of the global population is affected by peripheral nerve disorders, with the prevalence rising to 8% among older adults. Moreover, according to a report by NIH in August 2023, nerve compression syndrome is a commonly reported condition in the general population, with severity ranging from mild discomfort to severe impairment.

Chronic conditions such as diabetes are major contributors to nerve damage, often resulting in neuropathy. The global rise in diabetes prevalence, particularly type 2 diabetes, is directly correlated with an increasing demand for nerve repair and protective solutions. As per the Cleveland Clinic, Type 2 diabetes is the most common form, representing 90% to 95% of all diabetes cases, driving the nerve wrap market growth.

Minimally invasive surgical methods are increasingly preferred in peripheral nerve repair because of advantages such as reduced infection risk, faster recovery, and lower postoperative pain. Nerve wraps enhance these processes by covering the repaired nerve, lessening tension, and inhibiting scar tissue formation, resulting in enhanced functional recovery and long-term results. These advancements enhance safer and more effective surgeries and encourage broader nerve wrap application in clinical settings.

Global Nerve Wrap Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2030. For this study, Grand View Research has segmented the global nerve wrap market report based on surgery, application, and region.

  • Surgery Outlook (Revenue, USD Million, 2025 - 2030)
  • Direct Nerve Repair
  • Nerve Grafting
  • Application Outlook (Revenue, USD Million, 2025 - 2030)
  • Lower Extremities
  • Upper Extremities
  • Regional Outlook (Revenue, USD Million, 2025 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Surgery
    • 1.2.2. Application
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Surgery and Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Nerve Wrap Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Global Nerve Wrap Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Pipeline Analysis

Chapter 4. Global Nerve Wrap Market: Surgery Estimates & Trend Analysis

  • 4.1. Global Nerve Wrap Market: Surgery Dashboard
  • 4.2. Global Nerve Wrap Market: Surgery Movement Analysis
  • 4.3. Global Nerve Wrap Market by Surgery, Revenue
  • 4.4. Direct Nerve Repair
    • 4.4.1. Direct nerve repair market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Nerve Grafting
    • 4.5.1. Nerve grafting market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Nerve Wrap Market: Application Estimates & Trend Analysis

  • 5.1. Global Nerve Wrap Market: Application Dashboard
  • 5.2. Global Nerve Wrap Market: Application Movement Analysis
  • 5.3. Global Nerve Wrap Market by Application, Revenue
  • 5.4. Lower Extremities
    • 5.4.1. Lower extremities market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Upper Extremities
    • 5.5.1. Upper extremities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Nerve Wrap Market: Regional Estimates & Trend Analysis by Surgery, Application, and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 61.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
    • 7.3.4. Axogen Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Surgery benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Stryker
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Surgery benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Polyganics BV
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Surgery benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Integra LifeSciences Corporation.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Surgery benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Newrotex
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Surgery benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. AdvaCare Pharma
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Surgery benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Orthocell Ltd
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Surgery benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BioCircuit Technologies
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Surgery benchmarking
      • 7.3.11.4. Strategic initiatives